Log In
Print this Print this

Recombinant Human TNF receptor fusion protein

  Manage Alerts
Collapse Summary General Information
Company Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.
DescriptionRecombinant human TNF receptor 2-Fc fusion protein
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentPhase I
Standard IndicationArthritis
Indication DetailsTreat arthritis
Regulatory Designation
PartnerShanghai Pharmaceuticals Holding Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today